Publication:
Early glucose abnormalities in children with Cystic Fibrosis

ac.person.orcid 0000-0002-8600-1009
ac.person.orcid 0000-0001-9343-258X
ac.person.orcid 0000-0001-7111-0926
ac.person.position Staff
ac.person.position Staff
ac.person.position Staff
ac.person.position Staff
dc.contributor.advisor Verge, Charles
dc.contributor.advisor Widger, John
dc.contributor.advisor Ooi, (Keith) Chee
dc.contributor.author Prentice, Bernadette
dc.date.accessioned 2022-03-07T05:07:40Z
dc.date.available 2022-03-07T05:07:40Z
dc.date.issued 2021
dc.description.abstract Cystic Fibrosis (CF) is frequently complicated by Cystic Fibrosis-related diabetes (CFRD). CFRD has a direct impact on the morbidity of patients with CF and leads to early mortality. However, it is not yet known at what age pre-diabetic “early glucose abnormalities” begin or whether they are clinically important. The first study of the thesis was to determine whether children with CF less than ten years of age have glucose abnormalities and if present to examine the clinical importance of glucose abnormalities in this cohort that do not have diabetes. I was able to demonstrate that in children with CF, a high intermediate glucose peak on a 5-point Oral Glucose Tolerance Test (OGTT) is negatively correlated with both lung function and nutritional status. The poor clinical status of these children was not predicted by the two-hour level, the current gold standard diagnostic criterion for CFRD. This study also demonstrated that Continuous Glucose Monitoring (CGM) detected a higher frequency of glucose abnormities than the OGTT. The second part of the thesis evaluated the association between early indicators of airways disease (inflammation) and CGM detected glucose abnormalities in CF. I was able to show that children with pre-diabetic glucose abnormalities on CGM have a greater degree of pulmonary inflammation and were more likely to have a past history of Pseudomonas aeruginosa infection. In the third study, a longitudinal evaluation of these participants showed for the first time that for most children with CF who exhibit early glucose abnormalities, they will have glucose abnormalities that fluctuate. However, some children will exhibit persistently high glucose levels. The chapters of this thesis demonstrate for the first time the importance of pre-diabetic CGM detected glucose abnormalities in such young children with CF. These findings suggest that current screening recommendations will miss important, clinically significant glucose abnormalities that may impact on early lung disease in children with CF.
dc.identifier.uri http://hdl.handle.net/1959.4/100133
dc.language English
dc.language.iso en
dc.publisher UNSW, Sydney
dc.rights CC BY 4.0
dc.rights.uri https://creativecommons.org/licenses/by/4.0/
dc.subject.other Cystic Fibrosis
dc.subject.other Cystic Fibrosis-related diabetes
dc.subject.other Paediatrics
dc.subject.other Continuous Glucose Monitoring (CGM)
dc.title Early glucose abnormalities in children with Cystic Fibrosis
dc.type Thesis
dcterms.accessRights open access
dcterms.rightsHolder Prentice, Bernadette
dspace.entity.type Publication
unsw.accessRights.uri https://purl.org/coar/access_right/c_abf2
unsw.identifier.doi https://doi.org/10.26190/unsworks/2043
unsw.relation.faculty Medicine & Health
unsw.relation.school School of Women's & Children's Health
unsw.relation.school School of Women's & Children's Health
unsw.relation.school School of Women's & Children's Health
unsw.relation.school School of Women's & Children's Health
unsw.subject.fieldofresearchcode 42 HEALTH SCIENCES
unsw.thesis.degreetype PhD Doctorate
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
public version.pdf
Size:
3.81 MB
Format:
application/pdf
Description:
Resource type